Glioma
What's New
Last Posted: Nov 20, 2020
- Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH -Mutated Low-Grade Gliomas.
Gu Yuan et al. Frontiers in cell and developmental biology 2020 8586581 - Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma.
Park Changhee et al. Cancer research and treatment : official journal of Korean Cancer Association 2020 Nov - Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma.
Satomi Kaishi et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Oct - Genetic alterations in non-syndromic, familial gliomas in first degree relatives: A systematic review.
Vasilica Anca-Mihaela et al. Clinical neurology and neurosurgery 2020 Sep 198106222 - Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
Dono Antonio et al. Journal of neuro-oncology 2020 Oct - Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer.
Azenha Diana et al. Cancers 2020 Aug 12(9) - Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect different histological types and survival of glioma cases.
Pandith Arshad A et al. The journal of gene medicine 2020 Aug e3260 - DNA methylation analysis with methylation-sensitive high-resolution melting (MS-HRM) reveals gene panel for glioma characteristics.
Majchrzak-Celinska Aleksandra et al. CNS neuroscience & therapeutics 2020 Aug - High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray.
Feng Xiao et al. Oncology letters 2020 Sep 20(3) 2356-2368 - Personal Health Information Inference Using Machine Learning on RNA Expression Data from Patients With Cancer: Algorithm Validation Study.
Kweon Solbi et al. Journal of medical Internet research 2020 Aug 22(8) e18387 - A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Higa Nayuta et al. Cancer science 2020 Aug - Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen Jeanette K et al. Neuropathology and applied neurobiology 2020 Jul - A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients.
Wu Shan et al. Frontiers in oncology 2020 10871 - Brain extraction on MRI scans in presence of diffuse glioma: Multi-institutional performance evaluation of deep learning methods and robust modality-agnostic training.
Thakur Siddhesh et al. NeuroImage 2020 Jun 220117081 - Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
Oh Sejin et al. Nature communications 2020 Jul 11(1) 3288
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 29, 2020
- Content source: